thirty-nine patients with cancer-associated hypercalcaemia were randomly allocated to receive aminohydroxypropylidene diphosphonate ( apd ) , mithramycin , or corticosteroids and salmon calcitonin .
C0020437
hypercalcaemia
C0026234
mithramycin